# pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure

> **NCT07029906** · NA · RECRUITING · sponsor: **Imperial College London** · enrollment: 150 (estimated)

## Conditions studied

- Side-Effect
- Heart Failure

## Interventions

- **DRUG:** Bisoprolol 2.5 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07029906
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-29
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07029906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07029906, "pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07029906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*